GHRP-2 is among the peptides researched in the context of the growth hormone (GH) axis. Binds GHS-R1a on pituitary somatotroph cells, activating the Gq/PLC/IP3 pathway to trigger pulsatile GH release. Considered among the most potent GHRPs by peak GH output, with a cleaner profile than the related GHRP-6.
Studied as a research tool to probe pituitary GH secretory reserve and characterize dose-dependent GH-release pharmacodynamics — distinct from the more appetite-stimulating GHRP-6 and the structurally related hexarelin.
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
Numerous preclinical and some clinical studies exist on the GH axis, with evidentiary strength varying by substance.
References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.
We reply personally – via email or Telegram.